2-phenyl-9-(10-phenyl-6-pyridin-3-ylphenanthridin-2-yl)-1,10-phenanthroline
C42H26N4 — CID 146550015
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-phenyl-9-(10-phenyl-6-pyridin-3-ylphenanthridin-2-yl)-1,10-phenanthroline
2-phenyl-9-(10-phenyl-6-pyridin-3-ylphenanthridin-2-yl)-1,10-phenanthroline (PubChem CID 146550015) has the molecular formula C42H26N4 and a molecular weight of 586.70 g/mol. Its IUPAC name is 2-phenyl-9-(10-phenyl-6-pyridin-3-ylphenanthridin-2-yl)-1,10-phenanthroline.
Molecular Properties
| Compound Name | 2-phenyl-9-(10-phenyl-6-pyridin-3-ylphenanthridin-2-yl)-1,10-phenanthroline |
|---|---|
| PubChem CID | 146550015 |
| Molecular Formula | C42H26N4 |
| Molecular Weight | 586.70 g/mol |
| Exact Mass | 586.22 |
| IUPAC Name | 2-phenyl-9-(10-phenyl-6-pyridin-3-ylphenanthridin-2-yl)-1,10-phenanthroline |
| SMILES | c1ccc(-c2ccc3ccc4ccc(-c5ccc6nc(-c7cccnc7)c7cccc(-c8ccccc8)c7c6c5)nc4c3n2)cc1 |
| InChI | InChI=1S/C42H26N4/c1-3-9-27(10-4-1)33-14-7-15-34-39(33)35-25-31(20-23-38(35)46-40(34)32-13-8-24-43-26-32)37-22-19-30-17-16-29-18-21-36(28-11-5-2-6-12-28)44-41(29)42(30)45-37/h1-26H |
| InChIKey | SKLDDGVQLLZOJL-UHFFFAOYSA-N |
| XLogP | 10.55 |
| TPSA | 51.56 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 586.70 |
| LogP ≤ 5 | 10.55 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146550015 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.